XML 42 R31.htm IDEA: XBRL DOCUMENT v3.8.0.1
Allowance for Loan Losses (Tables)
3 Months Ended
Mar. 31, 2018
Receivables [Abstract]  
Summary of total non purchased and purchased loans
The following is a summary of non purchased loans and leases as of the dates presented:
 
 
March 31,
2018
 
December 31, 2017
Commercial, financial, agricultural
$
803,146

 
$
763,823

Lease financing
55,898

 
57,354

Real estate – construction
582,430

 
547,658

Real estate – 1-4 family mortgage
1,785,271

 
1,729,534

Real estate – commercial mortgage
2,503,680

 
2,390,076

Installment loans to individuals
103,059

 
103,452

Gross loans
5,833,484

 
5,591,897

Unearned income
(3,362
)
 
(3,341
)
Loans, net of unearned income
$
5,830,122

 
$
5,588,556

The following is a summary of purchased loans as of the dates presented:
 
 
March 31,
2018
 
December 31, 2017
Commercial, financial, agricultural
$
243,672

 
$
275,570

Real estate – construction
75,061

 
85,731

Real estate – 1-4 family mortgage
572,830

 
614,187

Real estate – commercial mortgage
960,273

 
1,037,454

Installment loans to individuals
16,112

 
18,824

Gross loans
1,867,948

 
2,031,766

Unearned income

 

Loans, net of unearned income
$
1,867,948

 
$
2,031,766

The following is a summary of total non purchased and purchased loans as of the dates presented:
 
 
March 31,
2018
 
December 31, 2017
Commercial, financial, agricultural
$
1,046,818

 
$
1,039,393

Lease financing
55,898

 
57,354

Real estate – construction
657,491

 
633,389

Real estate – 1-4 family mortgage
2,358,101

 
2,343,721

Real estate – commercial mortgage
3,463,953

 
3,427,530

Installment loans to individuals
119,171

 
122,276

Gross loans
7,701,432

 
7,623,663

Unearned income
(3,362
)
 
(3,341
)
Loans, net of unearned income
7,698,070

 
7,620,322

Allowance for loan losses
(46,401
)
 
(46,211
)
Net loans
$
7,651,669

 
$
7,574,111

Roll forward of the allowance for loan losses
The following table provides a roll forward of the allowance for loan losses and a breakdown of the ending balance of the allowance based on the Company’s impairment methodology for the periods presented:
 
Commercial
 
Real Estate -
Construction
 
Real Estate -
1-4 Family
Mortgage
 
Real Estate  -
Commercial
Mortgage
 
Installment
and  Other(1)
 
Total
Three Months Ended March 31, 2018
 
 
 
 
 
 
 
 
 
 
 
Allowance for loan losses:
 
 
 
 
 
 
 
 
 
 
 
Beginning balance
$
5,542

 
$
3,428

 
$
12,009

 
$
23,384

 
$
1,848

 
$
46,211

Charge-offs
(659
)
 

 
(671
)
 
(613
)
 
(122
)
 
(2,065
)
Recoveries
235

 
4

 
133

 
108

 
25

 
505

Net (charge-offs) recoveries
(424
)
 
4

 
(538
)
 
(505
)
 
(97
)
 
(1,560
)
Provision for loan losses charged to operations
1,953

 
766

 
(67
)
 
(965
)
 
63

 
1,750

Ending balance
$
7,071

 
$
4,198

 
$
11,404

 
$
21,914

 
$
1,814

 
$
46,401

Period-End Amount Allocated to:
 
 
 
 
 
 
 
 
 
 
 
Individually evaluated for impairment
$
272

 
$
1

 
$
168

 
$
1,026

 
$
5

 
$
1,472

Collectively evaluated for impairment
6,494

 
4,197

 
10,750

 
19,865

 
1,806

 
43,112

Purchased with deteriorated credit quality
305

 

 
486

 
1,023

 
3

 
1,817

Ending balance
$
7,071

 
$
4,198

 
$
11,404

 
$
21,914

 
$
1,814

 
$
46,401


 
Commercial
 
Real Estate -
Construction
 
Real Estate -
1-4 Family
Mortgage
 
Real Estate  -
Commercial
Mortgage
 
Installment
and  Other(1)
 
Total
Three Months Ended March 31, 2017
 
 
 
 
 
 
 
 
 
 
 
Allowance for loan losses:
 
 
 
 
 
 
 
 
 
 
 
Beginning balance
$
5,486

 
$
2,380

 
$
14,294

 
$
19,059

 
$
1,518

 
$
42,737

Charge-offs
(832
)
 

 
(275
)
 
(227
)
 
(264
)
 
(1,598
)
Recoveries
57

 
31

 
82

 
95

 
19

 
284

Net (charge-offs) recoveries
(775
)
 
31

 
(193
)
 
(132
)
 
(245
)
 
(1,314
)
Provision for loan losses charged to operations
401

 
(292
)
 
(1,939
)
 
3,146

 
184

 
1,500

Ending balance
$
5,112

 
$
2,119

 
$
12,162

 
$
22,073

 
$
1,457

 
$
42,923

Period-End Amount Allocated to:
 
 
 
 
 
 
 
 
 
 
 
Individually evaluated for impairment
$
165

 
$

 
$
1,139

 
$
2,670

 
$
3

 
$
3,977

Collectively evaluated for impairment
4,569

 
2,119

 
10,256

 
17,830

 
1,453

 
36,227

Purchased with deteriorated credit quality
378

 

 
767

 
1,573

 
1

 
2,719

Ending balance
$
5,112

 
$
2,119

 
$
12,162

 
$
22,073

 
$
1,457

 
$
42,923

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)
Includes lease financing receivables.

Investment in loans, net of unearned income on impairment methodology
The following table presents the fair value of loans purchased from Metropolitan as of the July 1, 2017 acquisition date.
At acquisition date:
 
July 1, 2017
  Contractually-required principal and interest
 
$
1,198,741

  Nonaccretable difference
 
(79,165
)
  Cash flows expected to be collected
 
1,119,576

  Accretable yield
 
(154,543
)
      Fair value
 
$
965,033

The following table provides the recorded investment in loans, net of unearned income, based on the Company’s impairment methodology as of the dates presented:
 
 
Commercial
 
Real Estate  -
Construction
 
Real Estate -
1-4 Family
Mortgage
 
Real Estate  -
Commercial
Mortgage
 
Installment
and  Other(1)
 
Total
March 31, 2018
 
 
 
 
 
 
 
 
 
 
 
Individually evaluated for impairment
$
2,848

 
$
399

 
$
13,737

 
$
7,802

 
$
420

 
$
25,206

Collectively evaluated for impairment
1,031,037

 
657,092

 
2,294,168

 
3,306,604

 
169,653

 
7,458,554

Purchased with deteriorated credit quality
12,933

 

 
50,196

 
149,547

 
1,634

 
214,310

Ending balance
$
1,046,818

 
$
657,491

 
$
2,358,101

 
$
3,463,953

 
$
171,707

 
$
7,698,070

December 31, 2017
 
 
 
 
 
 
 
 
 
 
 
Individually evaluated for impairment
$
3,064

 
$
1,777

 
$
14,482

 
$
10,545

 
$
439

 
$
30,307

Collectively evaluated for impairment
1,021,014

 
631,612

 
2,275,270

 
3,260,648

 
174,211

 
7,362,755

Purchased with deteriorated credit quality
15,315

 

 
53,969

 
156,337

 
1,639

 
227,260

Ending balance
$
1,039,393

 
$
633,389

 
$
2,343,721

 
$
3,427,530

 
$
176,289

 
$
7,620,322

 
(1)
Includes lease financing receivables.